Organization: University of Toronto

The Short Report, June 26, 2019: Dementia, Ontario chief scientist, AI for travel

The Canadian Consortium on Neurodegeneration in Aging is receiving $46 million over five years: $31.6 million from the Canadian Institutes of Health Research and $14.4 million from partners, including the Alzheimer Society. Headquartered at Baycrest in Toronto, the second phase of CCNA’s research program will include a large-scale study to evaluate the effectiveness of new…

Emerging Tech: Creating a Quantum Canada

Seed-stage companies are bolstering Canada’s position as a global leader in quantum science and technology. The question of how to maintain and grow that advantage—built through sustained investment in quantum research and development—has never been more urgent and is preoccupying academics, policymakers and innovators across the country.

The Short Report – May 8, 2019: Cannabis R&D, fuel cell demo, accelerator funding

With the goal becoming a mainstream healthcare company, Smiths Falls, ON-based Canopy Growth Corp. has spun off a new division – Spectrum Therapeutics – to oversee the company’s commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations, and recently acquired Germany-based C3Cannabinoid Compound Company, which develops cannabinoid-based medical therapies. – Canopy Growth…

Toronto’s Creative Destruction Lab receives $25 million through the Strategic Innovation Fund

The Government of Canada is investing $25 million in the University of Toronto’s Creative Destruction Lab (CDL), a non-profit project to pair science-based startups with business expertise. The investment comes through the Strategic Innovation Fund, a $1.26 billion federal program to spur innovation in Canada’s industrial and technological sectors, with a focus on large projects…